Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

X Filella

Showing results (31-40 of 120) with videos related to

Pageof 12
Sort By:
The Journal of Nuclear Medicine and Allied Sciences|October 1, 1990
Clinical usefulness of CEA as tumor marker in patients with colorectal cancerX Filella, R Molina, J L Bedini, et al.
The Prostate|August 22, 2000
Analysis of type T1 and T2 cytokines in patients with prostate cancerX Filella, J Alcover, M A Zarco, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|December 1, 1993
False positive values of PAP and PSA in complicated and non-complicated benign prostatic hypertrophyJ Alcover, X Filella, M A Barranco, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 23, 2000
Influence of AFP, CEA and PSA on the in vitro production of cytokinesX Filella, R Molina, J Alcover, et al.
Bulletin Du Cancer|January 1, 1992
Tumor associated glycoprotein-72 (TAG-72) levels in patients with non-malignant and malignant diseaseX Filella, R Molina, J Jo, et al.
Surgical Endoscopy|August 3, 1999
Peritoneal response to a septic challenge. Comparison between open laparotomy, pneumoperitoneum laparoscopy, and wall lift laparoscopyC Balagué, E M Targarona, M Pujol, et al.
Nephron|January 1, 1991
Tumor markers in chronic renal failure and hemodialysis patientsA Cases, X Filella, R Molina, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 5, 2013
Variability of assay methods for total and free PSA after WHO standardizationL Foj, X Filella, J Alcover, et al.
Anticancer Research|February 19, 2002
Free to complexed PSA ratio in differentiating benign prostate hyperplasia from prostate cancerX Filella, J Alcover, J M Corral, et al.
Bone|August 29, 2013
Effect of glucocorticoid treatment on Wnt signalling antagonists (sclerostin and Dkk-1) and their relationship with bone turnoverL Gifre, S Ruiz-Gaspà, A Monegal, et al.
Pageof 12

Showing results (31-40 of 120) with videos related to

Sort By:
Pageof 12
The Journal of Nuclear Medicine and Allied Sciences|October 1, 1990
Clinical usefulness of CEA as tumor marker in patients with colorectal cancerX Filella, R Molina, J L Bedini, et al.
The Prostate|August 22, 2000
Analysis of type T1 and T2 cytokines in patients with prostate cancerX Filella, J Alcover, M A Zarco, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|December 1, 1993
False positive values of PAP and PSA in complicated and non-complicated benign prostatic hypertrophyJ Alcover, X Filella, M A Barranco, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 23, 2000
Influence of AFP, CEA and PSA on the in vitro production of cytokinesX Filella, R Molina, J Alcover, et al.
Bulletin Du Cancer|January 1, 1992
Tumor associated glycoprotein-72 (TAG-72) levels in patients with non-malignant and malignant diseaseX Filella, R Molina, J Jo, et al.
Surgical Endoscopy|August 3, 1999
Peritoneal response to a septic challenge. Comparison between open laparotomy, pneumoperitoneum laparoscopy, and wall lift laparoscopyC Balagué, E M Targarona, M Pujol, et al.
Nephron|January 1, 1991
Tumor markers in chronic renal failure and hemodialysis patientsA Cases, X Filella, R Molina, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 5, 2013
Variability of assay methods for total and free PSA after WHO standardizationL Foj, X Filella, J Alcover, et al.
Anticancer Research|February 19, 2002
Free to complexed PSA ratio in differentiating benign prostate hyperplasia from prostate cancerX Filella, J Alcover, J M Corral, et al.
Bone|August 29, 2013
Effect of glucocorticoid treatment on Wnt signalling antagonists (sclerostin and Dkk-1) and their relationship with bone turnoverL Gifre, S Ruiz-Gaspà, A Monegal, et al.
Pageof 12